Effect of Pioglitazone on TIMP-3 and TACE in Type 2 Diabetes (PIO-TACE)
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01223196
Recruitment Status :
First Posted : October 18, 2010
Results First Posted : November 13, 2014
Last Update Posted : January 11, 2016
The University of Texas Health Science Center at San Antonio
Information provided by (Responsible Party):
Franco Folli, MD, The University of Texas Health Science Center at San Antonio